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This mini-review describes three biological systems. All three include competing
molecules and a limiting molecule that binds the competing molecules. Such systems
are extensively researched by economists. In fact, the issue of limited resources is the
defining feature of economic systems. Therefore, we call these systems “econsystems.”
In an econsystem, the allocation of the limiting molecule between the competing
molecules determines the behavior of the system. A cell is an example of an econsystem.
Therefore, a change in the allocation of a limiting molecule as a result of, for instance,
an abnormal change in the concentration of one of the competing molecules, may
result in abnormal cellular behavior, and disease. The first econsystem described in
this mini-review includes a long non-coding RNA and a messenger RNA (lncRNA and
mRNA). The limiting molecule is a microRNA (miRNA). The lncRNA and mRNA are
known as competing endogenous RNAs (ceRNAs). The second econsystem includes
two receptors, and the limiting molecule is a ligand. The third econsystem includes a
cis-regulatory element of a latent virus and that of a human gene. The limiting molecule
is a transcription complex that binds both cis-elements.
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This mini-review describes three econsystems: RNAs, receptors, and cis-regulatory elements.
All three systems include a limiting molecule that binds the competing molecule. Such systems are
extensively researched by economists. In fact, the issue of limited resources is the defining feature of
economic systems (Mas-Colell et al., 1995; Mankiw, 2014). This review shows that in all three cases,
the allocation of the limiting molecule between the competing molecules determines the behavior
of the system. We believe that these systems hold the key to some of the most important questions
in biology today.
The first type of econsystem described in this mini-review includes RNAs. Non-protein-coding
RNAs, excluding ribosomal and transfer RNAs, were previously thought to be non-functional (Tye
et al., 2015). They have been dismissed as background noise, serving no function in the cell. The two
major classes of ncRNAs are small ncRNAs (under 200 nt) and long non-coding RNAs (lncRNAs,
200 nt and longer). Furthermore, small ncRNAs are subdivided based on function and cellular
location. Subclasses include transfer RNA (tRNA), small nuclear RNA (snRNA), small nucleolar
RNA (snoRNA), small interfering RNA (siRNA), piwi-interacting RNA (piRNA), and microRNA
(miRNA). LncRNAs are present in a variety of sizes, from just over 200 nt to as long as several
Polansky and Javaherian 3-Econsystems: MicroRNAs, Receptors, and Latent Viruses
kb. MiRNAs regulate the expression of their target genes
post-transcriptionally by binding to themessenger RNA (mRNA)
(Liz and Esteller, 2016). Consequently, the binding of miRNA to
mRNA inhibits translation, or leads to degradation of the target
mRNA.
LncRNA also binds miRNA. This binding prevents the
miRNA from binding to the mRNA. The lncRNAs and mRNAs
that compete for miRNA binding are known as competing
endogenous RNAs (ceRNAs). These ceRNAs act as molecular
sponges for a miRNA through their miRNA binding sites,
referred to as miRNA response elements (MRE). By titrating
specific miRNAs, these MREs affect miRNA availability, and, in
turn, downstream processes. The binding of a miRNA to MREs
within themRNA leads to translational repression or degradation
of the mRNA (Tan et al., 2015). A lncRNA that has higher
density of MREs relative to the competing mRNA, and higher
concentration, has a significant post-transcriptional effect. Since
the concentration of miRNA is limiting, the lncRNA decreases
the availability of the miRNA to mRNA (see Figure 1A).
An example of a ceRNA, and its physiological consequences,
involves a lncRNA called colon cancer-associated transcript-
1 (CCAT1), which is up-regulated in gallbladder cancer
(GBC) tissues (Ma et al., 2015). CCAT1 up-regulates
the expression of Bmil, which is the target gene of
miRNA-218-5p, by competitively binding the miRNA,
promoting the proliferation and invasiveness of GBC
cells. CCAT1, therefore, exhibits an oncogenic effect
by modulating the availability of miRNA-218-5p, and
therefore, the expression of Bmi1. Knockdown of CCAT1
inhibited the proliferation and migration of GBC cells. By
“spongeing” miRNA-218-5p, CCAT1 may promote tumor
development.
In another study, a ceRNAwas identified that regulates cardiac
hypertrophy (Wang et al., 2014). In the study, Wang et al.
observed that the myeloid differentiation primary response gene
88 (Myd88), which is related to myocardial infarction induced
by ischemia/reperfusion, is down-regulated by miR-489. This
down-regulation inhibited hypertrophy. The study identified a
lncRNA called the Cardiac Hypertrophy Related Factor (CHRF),
that acts as a sponge, that is, decreases the availability of miR-
489. Consequently, the expression of CHRF induces hypertrophic
responses.
In a third study, Cesana et al. identified a muscle-specific
lncRNA, called linc-MD1, which has MREs for two specific
miRNAs, miR-133 and miR-135 (Cesana et al., 2011). These
two miRNAs target two mRNAs encoding for proteins that
function in myogenesis: the Myocyte-Specific Enhancer Factor
2C (MEF2C), targeted by miR-135, and the Mastermind-Like-1
(MAML1), targeted by miR-133. Depletion of the linc-MD1
lncRNA decreased the levels of both MAML1 and MEF2C
proteins, while over-expression of linc-MD1 increased the
protein levels. An increase in miR-133 and miR-135 levels,
in conditions of excess linc-MD1, decreased the expression
of MAML1 and MEF2C. These observations indicate a direct
competition for miRNA binding between linc-MD1 and the
mRNAs of MAML1 and MEF2C. The linc-MD1 lncRNA
levels are strongly reduced in Duchenne muscle cells, and
over-expression in these cells resulted in recovery of both
MAML1 and MEF2C synthesis. Linc-MD1, therefore, governs
the timing of muscle differentiation and myogenic alterations.
In the three examples above, themiRNA is limiting. Therefore,
the concentration of lncRNAs determines the availability of
miRNA for binding with its corresponding mRNA. This scarcity
of miRNAs turns the system into an econsystem.
The second econsystem described in this review includes
competing receptors and a limiting ligand that binds the
competing receptors. In this system, the ligandmolecules allocate
their binding time, or residence time, between the competing
receptors according to their affinity.
For example, consider a scenario where “L” is a ligand, “R1”
is the original receptor to which L binds, and “R2” and “R3”
are competitive receptors that also bind L but with 2 and 5
times higher affinity relative to R1, respectively (see Figure 1B). L
allocates 10% of its time bound to R1. Therefore, if one observes L
in the absence of a competitive receptor for 10min, he discovers
L bound to R1 for 1min. In other words, the “residence time” of L
on R1 is 1min. If R2 is present, L spends 2min bound to R2 (due
to a two-fold higher affinity). Therefore, L allocates its residence
time differently. Because 2 min is spent bound to R2, there is now
only 8min remaining. As mentioned previously, L allocates 10%
of its time bound to R1. As a result, in the presence of R2, L spends
only 0.8min bound to R1. Now let us consider a third receptor
R3. This receptor has a 5 times higher affinity to L compared to
R1. Therefore, L spends 5min bound to R3, and 0.5min bound
to R1. Note that an increase in the affinity of the competing
receptor lowers the residence time of the low affinity receptor
(see Figure 2A). Since the duration of the signal produced by
the L-R1 complex is directly related to the residence time of L at
R1 (Tummino and Copeland, 2008), the signal transduced from
L-R1 is reduced accordingly.
Note that the negative effect of a higher affinity receptor
on the residence time of a lower affinity receptor depends
on the existence of displacement asymmetry. To explain this
asymmetry, consider a case where two molecules compete for
binding to a third molecule. During this competition, the two
molecules try to displace each other. Displacement asymmetry
says that the probability of displacing the lower affinity molecule
by the higher affinity molecule is higher than the probability
of displacing the higher affinity molecule by the lower affinity
molecule. In other words, higher affinity means more displacing
power. The calculations in the example above assume an
extreme case where the probabilities are 1 for the higher affinity
receptor, and 0 for the lower affinity receptor. The displacement
asymmetry has many manifestations. One is binding order. For
instance, mineralocorticoid receptors (MR) show a much higher
affinity for binding to natural glucocorticoids than glucocorticoid
receptors (GR) (Quas and Fivush, 2009). Consequently, in the
presence of bothMRs and GRs, the MRs bind the glucocorticoids
first.
An example of a receptor econsystem involves the chemokine
receptors CXCR4 and CXCR7 (Coggins et al., 2014). Both
receptors bind the ligand CXCL12. The two receptors are
co-expressed under both normal and pathological conditions.
Furthermore, both receptors signal through β-arrestin 2
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FIGURE 1 | (A) Both mRNA and lncRNA have miRNA binding sites (miRNA response elements, or MRE), which bind miRNA. Since the concentration of miRNA is
limiting, the lncRNA decreases the availability of the miRNA to mRNA. (B) Residence Time. When observing the behavior of a ligand, L, for 10min, (i) in the presence
of R1 only, the observer sees L bound to the receptor 10% of the time (i.e., 1min). (ii) When observing the behavior of L in the presence of both R1 and R2, where R2
has 2 times more affinity for the ligand L than does R1, the residence time on R2 is 2min, and the residence time on R1 is 0.8 min (10% of the time L is free, that is,
8min). (iii) Consider R3 that has a 5 times higher affinity relative to R1. When observing the behavior of L in the presence of both R1 and R3, the residence time of R3
is 5 min. The residence time of R1 is, therefore, 10% of the time L is free, or unbound, that is, 10% of 5min, or 0.5min. (C) An increase in latent viral copy number
leads to a decrease in GABP•p300 availability to the cellular gene promoter (note the pink arrow). The result is a dysregulation in cellular gene expression.
dependent pathways. CXCR7 has a 10-fold higher binding
affinity for CXCL12 relative to CXCR4, and therefore CXCR7
functions are enhanced. Coggins et al. (2014) analyzed the
dynamics of CXCL12-dependent recruitment of β-arrestin 2 in
cells expressing CXCR4 (CXCR4+), CXCR7 (CXCR7+) or both
(CXCR4+-CXCR7+). The authors reported that CXCR7 “wins
the competition” and that expression of CXCR7 decreased the
magnitude and duration of β-arrestin 2 recruitment to CXCR4
and elevated the concentration of CXCL12 required to produce
a signal above basal levels. CXCL12 increased recruitment of β-
arrestin 2 to CXCR7 and decreased the association of β-arrestin
2 with CXCR4. In other words, CXCR7 sequestered β-arrestin 2
fromCXCR4 in cells with both receptors. Since the concentration
of ligand is limiting, the receptor with the higher binding affinity
decreases the availability of the ligand to the receptor with the
lower binding affinity.
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FIGURE 2 | (A) The chart above displays the relationship between binding
affinity and residence time. The x-axis represents the binding affinity of a
receptor, when this affinity is measured without the presence of R1. The y-axis
represents the residence time of the ligand on R1. The first data point
represents the residence time of L on R1 with no competitive receptors. The
second data point represents the residence time of L on R1 when both R2 and
R1 are present, and R2 has double the affinity of R1. The third data point
represents the residence time of L on R1 when both R3 and R1 are present,
and R3 has 5-times the affinity of R1. As the binding affinity of the competing
receptor increases, the residence time of L on R1 decreases. (B) Liu et al.
reports the expression level driven by the CMV enhancer/promoter (measured
in relative light units, or RLU) vs. those driven by the PDGF-b promoter in a
variety of cells. Based on the numbers on the y-axis, which are depicted
logarithmically, suggests that the CMV P/E is about 150-fold stronger than the
PDGF-b promoter.
In another study, Pawig et al. also report that CXCR7 regulates
ligand availability for CXCR4 (Pawig et al., 2015). The elevated
concentration of CXCL12 required to produce a signal above
basal levels, along with the decreased association of β-arrestin
2 with CXCR4, indicate a decreased CXCR4-CXCL12 residence
time resulting from the greater binding affinity of CXCR7
(see Figure 2 in the Coggins et al., 2014). Consequently, the
signal transduced from CXCR4 decreased as evidenced by the
decreased magnitude and duration of β-arrestin 2 recruitment
to CXCR4. The CXCL12/CXCR4 axis has been implicated
to be involved in hematopoietic stem and progenitor cell
(HSPC) homeostasis, progenitor cell survival and proliferation,
vascularization during development, and angiogenesis in the
context of ischemia. CXCR7 functions as a scavenger receptor
for CXCL12, downtuning CXCL12/CXCR4 signaling, and
consequently affecting many physiological processes. Wang and
Knaut refer to CXCR7 as an efficient chemokine sink due to
successful competition with CXCR4 for access to the ligand
(Wang and Knaut, 2014).
As described above, residence time is an indicator of binding
affinity between a ligand and a receptor. However, binding
affinity can also be defined by the ligand spatial distribution.
This is demonstrated in a study by DeWitt et al. (2002).
The authors objective was to determine whether differences in
epidermal growth factor receptor (EGFR)-binding affinity lead to
differences in spatial localization of autocrine epidermal growth
factor (EGF) ligands. The authors reported that decreasing the
binding affinity of an autocrine receptor/ligand pair decreased
ligand capture efficiency when ligand production was limiting for
receptor binding. The authors’ experimental data demonstrated
that cells can use ligand/receptor binding affinity to regulate
ligand spatial distribution when autocrine ligand production is
limiting for receptor signaling.
Both systems described above include competing molecules
and a limiting molecule that binds the competing molecules.
In the case of RNAs, the miRNA is limiting. In the case
of the receptors, the ligand is limiting. The limiting element
transforms the system into an econsystem. In such a system,
the allocation of the limiting element between the competing
molecules determines the behavior of the system. It is interesting
that in the book “Microcompetition with Foreign DNA and the
Origin of Chronic Disease,” another econsystem is described.
In this econsystem, the competing molecules are cis-regulatory
elements, called N-boxes, of latent viruses and cellular genes,
and the limiting molecule is the cellular transcription complex
GABP•p300 that binds both elements (Polansky, 2003).
The coactivator p300 is a 2414-amino acid protein initially
identified as a binding target of the E1A oncoprotein. Cbp is a
2441-amino acid protein initially identified as a transcriptional
activator bound to phosphorylated cAMP response element
(CREB) binding protein (hence, cbp). p300 and cbp share 91%
sequence identity and are functionally equivalent. Both p300 and
cbp are members of a family of proteins collectively referred to as
p300.
Although p300 and cbp are widely expressed, their cellular
availability is limited. Several studies demonstrated inhibited
activation of certain transcription factors resulting from
competitive binding of p300 to other cellular or viral proteins.
For example, competitive binding of p300, or cbp, to the
glucocorticoid receptor (GR), or the retinoic acid receptor
(RAR), inhibited activation of a promoter dependent on the AP-
1 transcription factor (Kamei et al., 1996). Competitive binding
of cbp to STAT1α inhibited activation of a promoter dependent
on both the AP-1 and ETS transcription factors (Horvai et al.,
1997). Competitive binding of p300 to STAT2 inhibited activation
of a promoter dependent on the NF-kB Re1A transcription
factor (Hottiger et al., 1998). Other studies also demonstrated the
limited availability of p300 (Polansky, 2003).
Since p300 is limiting, the GABP•p300 complex is also
limiting. Viral promoters/enhancers compete with cellular
promoters for this transcription complex. Just like the ceRNA
network discussed above, there are two competing entities that
compete for the binding of a limiting molecular complex.
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This competition was called Microcompetition (Polansky, 2003).
Consider the following highlights of this genetic econsystem, and
the role of latent viruses in this system.
Many viruses consist of an N-box, which is a core binding
sequence found in their promoters/enhancers. After establishing
a latent infection, the viral N-boxes bind the cellular GABP•p300
transcription complex. Since the complex is limiting, the viral
N-boxes decrease the availability of the complex to cellular
genes (see Figure 1C). As a result, the cellular genes express an
abnormal level of their protein. Those that are stimulated by the
GABP•p300 complex produce fewer proteins, and those that are
suppressed by the complex producemore proteins. The abnormal
levels of these cellular proteins can cause a disease.
Latent viruses have been dismissed as harmless, with no effect
on the host cellular processes. However, many common viruses,
which establish a latent infection, have a strong N-box in their
promoters/enhancers. These viruses include the Epstein-Barr
virus (EBV), Cytomegalovirus (CMV), Herpes Simplex Virus 1
(HSV-1), Human Immunodeficiency Virus (HIV), and Human
T-cell lymphotropic virus (HTLV). It is interesting that the
CMV has the strongest promoter/enhancer known to science.
To estimate the effect of microcompetition with a latent CMV
on the infected cell, one can combine the results from a few
studies. Results from Liu et al. (2004) can be used to estimate
the strength of the CMV promoter/enhancer, which includes the
N-box, relative to the strength of the promoter of the cellular
platelet-derived growth factor-b chain (PDGF-b) gene. Liu et al.
reports the expression level driven by the CMV E/P (that is,
the CMV enhancer/promoter) vs. those driven by the PDGF-b
promoter in a variety of cells, including the COS-7, KB3-1, U251,
PC12, and C17.2 cells (see Figure 2B). A close inspection of the
numbers on the y-axis shown in Figure 2B, which are depicted
logarithmically, suggests that the CMV P/E is about 150-fold
stronger than the PDGF-b promoter. We suspect that the reason
for this difference is the much higher affinity between the CMV
promoter/enhancer and the GABP•p300 transcription complex
relative to the affinity between the PDGF-b promoter and this
complex. Slobedman and Mocarski showed that during latency,
an infected cell harbors about 10 copies of the CMV (Slobedman
and Mocarski, 1999). Therefore, the impact of a latent infection
with the CMV on the residence time of the GABP•p300 complex
on cellular genes, or the spatial distribution of the GABP•p300
complex around cellular genes, is equivalent to the impact created
by the introduction of 1500 copies of additional PDGF-b genes
into the cell. Adam et al. showed that PDGF-b is susceptible
to microcompetition with CMV (Adam et al., 1996). Therefore,
according to Microcompetition theory, a latent CMV infection
would result in a decrease in PDGF-b transcription followed by
a decrease in the concentration of the expressed protein in the
latently infected cell, ultimately leading to disease.
In “Microcompetition with Foreign DNA and the Origin of
Chronic Disease,” the connection betweenmicrocompetition and
most major diseases is developed. The tissue factor (TF), CD18,
and CD49d genes are all suppressed by GABP. Furthermore,
according to the theory, microcompetition between the latent
virus and these genes for GABP increases their transcription,
thereby increasing the risk of cardiovascular and autoimmune
diseases. In contrast, the BRCA1 and retinoblastoma (Rb)
tumor suppressor genes are transactivated by GABP and
microcompetition between these genes and the latent virus
decreases their transcription, increasing the risk of cancer.
We believe that an increase in the number of latent viral
promoters/enhancers is the event that triggers the development
of most major diseases. In other words, the increase in the
number of viral promoters/enhancers is the disruption that shifts
the genetic econsystem from normal to abnormal, or from health
to disease. There are many events that increase the number
of latent viruses in infected individuals. One such event is
an increase in the level of stress. In a recent paper, Polansky
and Javaherian used the Microcompetition theory to explain
how stress can cause breast cancer in women infected with a
latent virus (Polansky and Javaherian, 2015). As it turns out,
most people harbor a latent viral infection. Seroprevalence of
CMV is greater than 70–80% by the age of 50 (Reddehase,
2013). Furthermore, more than 90–95% are infected with the
EBV (Green and Michaels, 2013). The HSV-1 has an estimated
seroprovalence of greater than 90% in many nations (Bernstein
et al., 2013). Therefore, most people should do everything they
can to protect their genetic econsystem, and prevent an increase
in the number of latent viral promoters/enhancers. Otherwise,
according to Microcompetition theory, these people will develop
amajor disease, such as cancer, heart disease, stroke, diabetes, and
many autoimmune diseases.
To summarize, competition for limited resources is a hallmark
of economical systems. As we showed in this mini-review,
scientists are starting to realize that certain biological systems
behave in similar ways. We believe that this discovery is
very promising, and has the potential to revolutionize our
understanding of the etiology of most major diseases.
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